Sage lays off half of R&D team, shakes up C-suite again
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*
